These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29802901)

  • 1. Preclinical Canine Model of Graft-versus-Host Disease after In Utero Hematopoietic Cell Transplantation.
    Vrecenak JD; Pearson EG; Todorow CA; Li H; Johnson MP; Flake AW
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1795-1801. PubMed ID: 29802901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.
    Peranteau WH; Heaton TE; Gu YC; Volk SW; Bauer TR; Alcorn K; Tuschong LM; Johnson MP; Hickstein DD; Flake AW
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):293-305. PubMed ID: 19203720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.
    Vrecenak JD; Pearson EG; Santore MT; Todorow CA; Li H; Radu A; Bhatti T; Peranteau WH; Johnson MP; Flake AW
    Blood; 2014 Sep; 124(12):1987-95. PubMed ID: 24869940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero hematopoietic stem cell transplantation: progress toward clinical application.
    Merianos D; Heaton T; Flake AW
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):729-40. PubMed ID: 18541191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
    Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
    Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model.
    Shi C; Li Z; Sun Z; Pan L
    Transplant Cell Ther; 2024 Apr; 30(4):398.e1-398.e10. PubMed ID: 38331194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple Approach to Increase Donor Hematopoietic Stem Cell Dose and Improve Engraftment in the Murine Model of Allogeneic In Utero Hematopoietic Cell Transplantation.
    Vrecenak JD; Partridge EA; Pearson EG; Flake AW
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):e21-e24. PubMed ID: 31493540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
    Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
    Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal allotransplant recipients are resistant to graft-versus-host disease.
    Riley JS; McClain LE; Stratigis JD; Coons BE; Bose SK; Dave A; White BM; Li H; Loukogeorgakis SP; Fachin CG; Dias AIBS; Flake AW; Peranteau WH
    Exp Hematol; 2023 Feb; 118():31-39.e3. PubMed ID: 36535408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-Existing Maternal Antibodies Cause Rapid Prenatal Rejection of Allotransplants in the Mouse Model of In Utero Hematopoietic Cell Transplantation.
    Riley JS; McClain LE; Stratigis JD; Coons BE; Li H; Hartman HA; Peranteau WH
    J Immunol; 2018 Sep; 201(5):1549-1557. PubMed ID: 30021770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
    Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.
    Durkin ET; Jones KA; Rajesh D; Shaaban AF
    Blood; 2008 Dec; 112(13):5245-53. PubMed ID: 18796629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
    Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.
    Peranteau WH; Hayashi S; Abdulmalik O; Chen Q; Merchant A; Asakura T; Flake AW
    Blood; 2015 Sep; 126(10):1245-54. PubMed ID: 26124498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.